Source: Virtual Congress 2020 – Respiratory infections
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
A. Skrahin (Minsk, Belarus). Successful management of a patient with triple infection (MDR-TB/HIV/HCV) using new WHO recommendations. Virtual Congress 2020 – Respiratory infections

Member's Comments

No comment yet.

Related content which might interest you: Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Clinical management: recommended practice including the place of antibiotics Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection Year: 2007 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 Treatment outcome of multi drug resistant tuberculosis patients in modified DOTS-PLUS: A new strategy Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Treatment outcome of multi drug resistant tuberculosis patients in modified DOTS-PLUS: A new strategy Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 Therapeutic strategies: what treatment for what patient Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP) Year: 2008 The standardised treatment of pulmonary TB: outcomes, problems and suggestions Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties Year: 2005 ERS short guidelines on COVID-19 management Source: ERS webinar 2021: ERS short guidelines on COVID-19 management Year: 2021 Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion Source: Eur Respir J 2015; 45: 1170-1173 Year: 2015 Monitoring results of diagnostics and treatment of new TB patients in Uliyanovsk region Source: Annual Congress 2010 - Global tuberculosis control Year: 2010 WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Source: Eur Respir J 2011; 38: 516-528 Year: 2011 Treatment patients with pulmonary tuberculosis (PT) and accompanying pathologies by DOTS strategy Source: Eur Respir J 2005; 26: Suppl. 49, 192s Year: 2005 Clinical effectiveness of triple therapy in the management of COPD: A systematic review Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020 Year: 2021 Challenges in the prevention, diagnosis, and treatment of tuberculosis in children Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management Year: 2019 COPD self management: The impact of implementing self management plans & rescue medications across 3 hospitals Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012 How do the new guidelines work? Practical approach to the new guidelines for asthma diagnosis in children, discussion and Q&A Source: Virtual Congress 2021 – The ERS guidelines for the diagnosis of asthma in children aged 5-16 years Year: 2021